SCHEMBL23980842

SCHEMBL23980842

CCCCC(C)(CNC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C)Nc1nc(Cl)nc2cnccc12

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.44
▸ LATS1 O95835 5/20 0.41
▸ LATS2 Q9NRM7 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ SCN5A Q14524 1/20 0.39
▸ SCN3A Q9NY46 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ BUB1 O43683 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ POLB P06746 3/20 0.38
▸ FKBP1A P62942 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ LMNA P02545 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23980746 0.85 POLB (0.47) ALDH1A1SMN1; SMN2SCN5ASCN3AL3MBTL1
SCHEMBL23980844 0.83 L3MBTL1 (0.40) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL23980846 0.80 PRCP (0.40) LATS1LATS2
SCHEMBL19924283 0.78 LATS1 (0.43) LATS1LATS2
SCHEMBL19924282 0.78 LATS1 (0.43) LATS1LATS2
SCHEMBL23980848 0.74 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2SCN5ASCN3AL3MBTL1
SCHEMBL23785461 0.70 TLR8 (0.40) LATS1LATS2
SCHEMBL23785495 0.70 SMN1; SMN2 (0.54) ALDH1A1SMN1; SMN2SCN5ASCN3AL3MBTL1
SCHEMBL28629956 0.69 KMT2A (0.66) ALDH1A1SMN1; SMN2SCN5ASCN3AL3MBTL1
SCHEMBL6242176 0.69 KMT2A (0.66) ALDH1A1SMN1; SMN2SCN5ASCN3AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210340141-A1 TLR8 AGONIST CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2021-11-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340141-A1 TLR8 AGONIST TLR8, TLR7, TLR1 ALDH1A1 3196/4885LATS1 3229/4885LATS2 3353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback